Impact of environmental pollution and weather changes on the incidence of ST-elevation myocardial infarction.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
25 10 2021
Historique:
received: 25 03 2020
accepted: 01 05 2020
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 5 4 2022
Statut: ppublish

Résumé

Environmental pollution and weather changes unfavorably impact on cardiovascular disease. However, limited research has focused on ST-elevation myocardial infarction (STEMI), the most severe yet distinctive form of acute coronary syndrome. We appraised the impact of environmental and weather changes on the incidence of STEMI, analysing the bivariate and multivariable association between several environmental and atmospheric parameters and the daily incidence of STEMI in two large Italian urban areas. Specifically, we appraised: carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NOX), ozone, particulate matter smaller than 10 μm (PM10) and than 2.5 μm (PM2.5), temperature, atmospheric pressure, humidity and rainfall. A total of 4285 days at risk were appraised, with 3473 cases of STEMI. Specifically, no STEMI occurred in 1920 (44.8%) days, whereas one or more occurred in the remaining 2365 (55.2%) days. Multilevel modelling identified several pollution and weather predictors of STEMI. In particular, concentrations of CO (p = 0.024), NOX (p = 0.039), ozone (p = 0.003), PM10 (p = 0.033) and PM2.5 (p = 0.042) predicted STEMI as early as three days before the event, as well as subsequently, and NO predicted STEMI one day before (p = 0.010), as well as on the same day. A similar predictive role was evident for temperature and atmospheric pressure (all p < 0.05). The risk of STEMI is strongly associated with pollution and weather features. While causation cannot yet be proven, environmental and weather changes could be exploited to predict STEMI risk in the following days.

Sections du résumé

BACKGROUND
Environmental pollution and weather changes unfavorably impact on cardiovascular disease. However, limited research has focused on ST-elevation myocardial infarction (STEMI), the most severe yet distinctive form of acute coronary syndrome.
METHODS AND RESULTS
We appraised the impact of environmental and weather changes on the incidence of STEMI, analysing the bivariate and multivariable association between several environmental and atmospheric parameters and the daily incidence of STEMI in two large Italian urban areas. Specifically, we appraised: carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NOX), ozone, particulate matter smaller than 10 μm (PM10) and than 2.5 μm (PM2.5), temperature, atmospheric pressure, humidity and rainfall. A total of 4285 days at risk were appraised, with 3473 cases of STEMI. Specifically, no STEMI occurred in 1920 (44.8%) days, whereas one or more occurred in the remaining 2365 (55.2%) days. Multilevel modelling identified several pollution and weather predictors of STEMI. In particular, concentrations of CO (p = 0.024), NOX (p = 0.039), ozone (p = 0.003), PM10 (p = 0.033) and PM2.5 (p = 0.042) predicted STEMI as early as three days before the event, as well as subsequently, and NO predicted STEMI one day before (p = 0.010), as well as on the same day. A similar predictive role was evident for temperature and atmospheric pressure (all p < 0.05).
CONCLUSIONS
The risk of STEMI is strongly associated with pollution and weather features. While causation cannot yet be proven, environmental and weather changes could be exploited to predict STEMI risk in the following days.

Identifiants

pubmed: 34695216
pii: 6410025
doi: 10.1177/2047487320928450
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1501-1507

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Giuseppe Biondi-Zoccai (G)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy.
Mediterranea Cardiocentro, Italy.

Giacomo Frati (G)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy.
IRCCS NEUROMED, Italy.

Achille Gaspardone (A)

Division of Cardiology, Ospedale S. Eugenio, Italy.

Enrica Mariano (E)

Division of Cardiology, Tor Vergata University, Italy.

Alessandro D Di Giosa (AD)

ARPA Lazio, Italy.

Andrea Bolignano (A)

ARPA Lazio, Italy.

Angela Dei Giudici (A)

Division of Cardiology, Santa Maria Goretti Hospital, Italy.

Simone Calcagno (S)

Division of Cardiology, Santa Maria Goretti Hospital, Italy.

Massimiliano Scappaticci (M)

Division of Cardiology, Santa Maria Goretti Hospital, Italy.

Sebastiano Sciarretta (S)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy.
IRCCS NEUROMED, Italy.

Valentina Valenti (V)

Division of Cardiology, Santa Maria Goretti Hospital, Italy.

Rebecca Casati (R)

Division of Cardiology, Santa Maria Goretti Hospital, Italy.

Giuseppe Visconti (G)

ASL Latina, Italy.

Maria Penco (M)

Division of Cardiology, University of L'Aquila, Italy.

Maria B Giannico (MB)

Division of Cardiology, Ospedale S. Eugenio, Italy.

Mariangela Peruzzi (M)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy.
Mediterranea Cardiocentro, Italy.

Elena Cavarretta (E)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy.
Mediterranea Cardiocentro, Italy.

Simone Budassi (S)

Division of Cardiology, Tor Vergata University, Italy.

Joseph Cosma (J)

Division of Cardiology, Tor Vergata University, Italy.

Massimo Federici (M)

Department of Systems Medicine, Tor Vergata University, Italy.

Leonardo Roever (L)

Department of Clinical Research, Federal University of Uberlandia, Brazil.

Francesco Romeo (F)

Division of Cardiology, Tor Vergata University, Italy.

Francesco Versaci (F)

Division of Cardiology, Santa Maria Goretti Hospital, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH